Delivery Order SPE2DB24D2101-SPE2DB24FKGAN

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Abiraterone Acetate 250 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,546.31, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of Abiraterone Acetate 250 mg tablets to the Defense Logistics Agency (DLA). The $3,021.54 fixed-price delivery order with a completion date of February 9, 2024 was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. AmerisourceBergen is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,679.26 firm fixed-price delivery order is for the supply of 4,565,672,909 units of abiraterone acetate 250 mg tablets. The award has a completion date of September 5, 2024 and was made on September 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,182.10 firm fixed-price delivery order contract is for the supply of 4,565,950,374 units of abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of September 27, 2024. This delivery order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of ABIRATERONE ACETATE 250 MG TAB 120S. The firm-fixed-price Delivery Order is valued at $16,991.13 and has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This federal contract award is for the delivery of Abiraterone Acetate 250 mg tablets to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $3,421.36 and is a delivery order with a firm fixed price. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of abiraterone acetate 250 mg tablets. The contract has a ceiling value of $1,610.20 and a completion date of February 26, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,667.28 firm fixed price delivery order contract (SPE2DB22D1017|SPE2DB24FF5LH) to provide 4,564,184,345 units of Abiraterone Acetate 250 mg tablets. This delivery order is under an indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Abiraterone Acetate 500mg tablets, a prescription medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,920.00 and an ultimate completion date of July 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of abiraterone acetate 250 mg tablets. The contract, valued at $13,348.20, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKGAN
    Delivery Order

This federal contract award is for the delivery of abiraterone acetate 250 mg tablets (120 count) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order with a firm fixed price of $2,778.80 and an ultimate completion date of August 22, 2024. The contract has no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, for supplying a range of pharmaceutical and medical products to support military treatment programs and other federal healthcare needs nationwide.

Generated 11/20/24, 9:03 AM